Summary: Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor against a broad range of HIV subtypes, and inhibits the HIV-1 integrase catalyzed strand transfer reaction with IC50 of 3.0 nM. Phase 2. https://www.bocsci.com/cabotegravir-gsk744-gsk1265744-cas-1051375-10-0-item-463362.html